as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹12.42
Change
-0.58 (-4.46%)
Open
₹12.95
Prev. Close
₹13.0
Day High
₹13.3
Day Low
₹12.0
Volume Analysis
Traded
35,080
Delivered
22,929
Delivery %
65.36%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (2)
- •Promoter holding is falling
- •Below-average fundamentals quality score (26/100)
Opportunities (1)
- •FII holding has been rising
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹14.44 | ₹13.87 | ₹13.14 | ₹12.57 | ₹11.84 | ₹11.27 | ₹10.54 |
| Fibonacci | ₹13.87 | ₹13.37 | ₹13.07 | ₹12.57 | ₹12.07 | ₹11.77 | ₹11.27 |
| Camarilla | ₹12.78 | ₹12.66 | ₹12.54 | ₹12.57 | ₹12.3 | ₹12.18 | ₹12.06 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-10.0%
1 Week
-8.34%
1 Month
-8.2%
3 Months
-21.84%
6 Months
-18.98%
1 Year
+3.5%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Company Overview
Sector
Healthcare
Market Cap
₹11 Cr
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 19 Nov 2026. Not investment advice.
TopFund Analysis
Ortin Global Limited scores weakly on TopFund's composite fundamentals check within the Healthcare sector, at 26/100. The strongest factor is Institutional Ownership (51/100), while Valuation (0/100) is the weakest area to weigh before deciding. Notably: Promoter holding is falling; below-average fundamentals quality score (26/100). FII holding has been rising.
TopFund Score — Fundamentals Quality
26/100 — WeakData confidence: 61/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Valuation
Corporate Governance
Momentum
Institutional Ownership
Risk & Volatility
Liquidity
From Screener.in
- −Promoter holding is low: 1.24%
- −Promoter holding has decreased over last 3 years: -6.13%
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Board approved Q2/H1 FY27 unaudited results; Mathesh & Ramana resigned, S.D. Mehta & Co. appointed from 12 Nov 2026.
Board approved Q2 FY27 results; auditor resigned 12 Nov 2026, S.D. Mehta & Co. appointed.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Jun 2011 | Mar 2012 | Jun 2012 | |
|---|---|---|---|
| Sales + | 20 | 20 | 16 |
| Expenses + | 17 | 21 | 14 |
| Operating Profit | 3 | -1 | 2 |
| OPM % | 13.53% | -5.06% | 13.06% |
| Other Income + | 0 | 0 | 0 |
| Interest | 1 | 1 | 1 |
| Depreciation | 0 | 0 | 0 |
| Profit before tax | 2 | -2 | 1 |
| Tax % | 33.33% | -11.93% | 33.33% |
| Net Profit + | 1 | -2 | 0 |
| EPS in Rs | 3 | -1 | 0 |
| Raw PDF | — | — | — |
| YoY Sales growth | — | — | -20 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 92.64% | 98.76% | 92.53% | 92.52% | 92.52% | 92.24% | 92.24% | 97.08% | 97.09% | 97.1% | 96.96% | 98.09% |
| Promoters | 7.36% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.24% |
| FII | 0.0% | 0.0% | 6.25% | 6.25% | 6.25% | 6.53% | 6.53% | 1.68% | 1.68% | 1.68% | 1.8% | 0.67% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Ortin Global Limited (this stock) | 11 | — | — | — |
| Gkb Ophthalmics Ltd. | 31 | 11.2 | 0.56 | 3.28% |
| Medi Caps Ltd. | 33 | — | 0.27 | -9.21% |
| Vivo Bio Tech Ltd. | 35 | — | 0.37 | -2.24% |
| Vivimed Labs Limited | 43 | — | -0.2 | — |
| Mangalam Drug & Chem Ltd | 45 | — | 0.51 | -35.3% |
| Sunil Healthcare Ltd. | 78 | 26.6 | 1.03 | 6.01% |
Which Mutual Funds Hold Ortin Global Limited?
Frequently Asked Questions about Ortin Global Limited
Ortin Global Limited (ORTINGLOBE) closed at ₹12.42 on NSE on 19 November 2026, down 0.58 (4.46%) from the previous close.
Ortin Global Limited trades on the NSE (National Stock Exchange of India) under the symbol ORTINGLOBE.
Ortin Global Limited has a dividend yield of 0.0%.
Ortin Global Limited's 52-week high is ₹21.3 and its 52-week low is ₹11.0.
Ortin Global Limited has a market capitalisation of ₹11 crore.
Ortin Global Limited has a TopFund Quality Score of 26/100 (Weak), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Ortin Global Limited?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.